Please assess the completion status of the following clinical trial:

Trial Title: Epiduo Pediatric Acne Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of acne vulgaris with facial involvement~* Score of 3 (moderate) on the Investigator's Global Assessment (IGA) scale~* A minimum of 20 but not more than 100 total lesions (Noninflammatory and/or Inflammatory) on the face (including the nose) at Baseline~Exclusion Criteria:~* Acne nodule or acne cyst~* Acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.), or severe acne requiring systemic treatment~* Underlying diseases and/or dermatologic conditions that require the use of interfering topical or systemic therapy or that might interfere with study assessments~* Use of prohibited medications prior to the study and/or are unwilling to refrain from such use during the study

- Gender: ALL
- Minimum Age: 9 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- adapalene/benzoyl peroxide (Type: ACTIVE_COMPARATOR): Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% applied topically once daily for 12 weeks
- Topical Gel Vehicle (Type: PLACEBO_COMPARATOR): Topical Gel Vehicle applied topically once daily for 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).